Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62K Hold
38
﹤0.01% 700
2026
Q1
$1.83K Buy
+38
New +$1.77K ﹤0.01% 652
2025
Q3
Sell
-34
Closed -$1.64K 692
2025
Q2
$1.64K Buy
+34
New +$1.74K ﹤0.01% 571
2024
Q4
Sell
-30
Closed -$1.73K 573
2024
Q3
$1.73K Sell
30
-110
-79% -$5.94K ﹤0.01% 531
2024
Q2
$6.79K Hold
140
﹤0.01% 469
2024
Q1
$6.8K Hold
140
﹤0.01% 410
2023
Q4
$6.96K Buy
+140
New +$6.85K ﹤0.01% 434

Other funds holding SNY

Arlington Trust's SNY Position: Q2 2026 in Review

Arlington Trust held its Sanofi (SNY) position steady in Q2 2026 at 38 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Arlington Trust first reported a position in SNY in Q4 2023 and has held it in 7 quarters since. The position peaked at $6.96K in Q4 2023. 86 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Arlington Trust held 38 shares of Sanofi worth $1.62K as of Q2 2026.
  • Arlington Trust left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #700 holding.
  • Arlington Trust first reported a position in Sanofi in Q4 2023 and has held it in 7 quarters since.
  • Arlington Trust's Sanofi position peaked at $6.96K in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.